When to biopsy and when to stop biopsying.
With the widespread use of serum prostate-specific antigen (PSA) and transrectal ultrasound-guided needle biopsy of the prostate in men with suspected prostate cancer, physicians are faced with the dilemma of treating a patient with a high index of suspicion of prostate cancer but with an initial set of negative biopsies. For the initial biopsy, the optimal number of biopsy cores for detecting prostate cancer in prostate biopsy remains controversial; it is also often unclear who should undergo a repeat prostatebiopsy and when to stop biopsying.
Djavan
Bob
B
Department of Urology, University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. bdjavan@hotmail.com
Remzi
Mesut
M
Marberger
Michael
M
D001707:Biopsy, Needle; D003657:Decision Making; D006801:Humans; D008297:Male; D016571:Neural Networks, Computer; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000601:surgery; D012372:ROC Curve; D012680:Sensitivity and Specificity
D017430:Prostate-Specific Antigen